Page last updated: 2024-08-26

phorbolol myristate acetate and Sclerosis, Systemic

phorbolol myristate acetate has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amin, MA; Arasu, E; Balogh, B; Campbell, PL; Haines, GK; Kahaleh, B; Khanna, D; Koch, AE; Lozier, A; Ohara, RA; Rabquer, BJ; Renauer, PA; Schiopu, E; Stinson, WA; Tsou, PS; Zakhem, G	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Sclerosis, Systemic

Article	Year
Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines. Rheumatology (Oxford, England), 2016, Volume: 55, Issue:4 Topics: Angiogenesis Inducing Agents; Case-Control Studies; Cells, Cultured; Chemokines; Chemotaxis; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inhibitor of Differentiation Protein 1; Male; Middle Aged; Neovascularization, Pathologic; Receptors, Interleukin-8B; Scleroderma, Systemic; Signal Transduction; Skin; Tetradecanoylphorbol Acetate	2016

Article

Year

Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.

Rheumatology (Oxford, England), 2016, Volume: 55, Issue:4

Topics: Angiogenesis Inducing Agents; Case-Control Studies; Cells, Cultured; Chemokines; Chemotaxis; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inhibitor of Differentiation Protein 1; Male; Middle Aged; Neovascularization, Pathologic; Receptors, Interleukin-8B; Scleroderma, Systemic; Signal Transduction; Skin; Tetradecanoylphorbol Acetate

2016